Enliven Therapeutics, Inc. 10-Q

Accession 0000950170-23-021262

Filing information

CIK: 0001672619
Report date: 2023-03-31
Filing date: 2023-05-11
Form: 10-Q
Primary document: elvn-20230331.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.